How it works
Get started by filling out the online enrollment application to find out if you are eligible for assistance.
NiceRx verifies your eligibility for medication assistance and notifies you if you are pre-qualified. The pharmaceutical company provides your medication for free, and you only pay our service fee.
We will request documents to be submitted by you and your healthcare provider that are required by the pharmaceutical company to complete your enrollment.
Once approved, the pharmaceutical company typically ships a 90-day supply of medication to your home or healthcare provider’s address. Final acceptance is determined by the pharmaceutical company.
Your monthly Retevmo cost savings if eligible
If you are eligible for the Retevmo patient assistance program you can receive your medication for free. Our monthly service fee of $49 per medication covers the cost of our services in applying for the program and requesting your ongoing refills on your behalf. If you obtain your Retevmo through NiceRx, you will only pay $49 a month regardless of the retail price of your medication.
Am I eligible for the Retevmo patient assistance program?
You could receive your Retevmo without paying the full retail price if you meet the eligibility criteria for assistance. The eligibility requirements are set by the pharmaceutical companies that are providing assistance programs. At NiceRx, we review each application individually, although the main factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for Retevmo patient assistance?
We do everything that we can to take the hassle and stress out of applying for patient assistance programs. Simply start by filling in our enrollment application. We will ask for details about your healthcare provider, your insurance, and your household income. This information is required by the pharmaceutical companies you are applying to for assistance. We may also be able to help you access patient assistance for other medications that you have been prescribed, so be sure to tell us about any medications you are taking as well as Retevmo.
NiceRx will review the information you have provided, and if we determine that you may be eligible for assistance, we will seek to enroll you in the Retevmo patient assistance program. We will handle the enrollment process for you by working with your healthcare provider and preparing all the required paperwork for your doctor to sign. We will also request your Retevmo medication refills on your behalf for up to 1 year once you are enrolled in the program.
Is NiceRx a Retevmo coupons provider?
At NiceRx, we help eligible individuals access the Retevmo patient assistance program. This means that we are not a Retevmo coupon, a Retevmo discount card, or a Retevmo copay card provider. We do not offer any medication trial offers or free Retevmo samples.
Can NiceRx help me get Retevmo if I have insurance?
We may be able to help you if you have insurance, including if your insurance company will not pay for your Retevmo medication, or you have a high copay or coinsurance responsibility. We may even be able to assist if you do not have insurance. Please fill in our enrollment application to find out more.
How much does Retevmo cost without insurance?
Retevmo costs without insurance will vary depending on how much you buy and the retailer you buy it from. As a guide, Retevmo oral capsule 80 mg will typically cost around $10,800 for 60 capsules. If you obtain your medication through NiceRx, you will pay a flat monthly rate of $49 per medication regardless of its retail price.
How much does Retevmo cost with insurance?
The copay of Retevmo will vary in line with the specific terms of your healthcare plan. For further details about what you may need to pay, your insurance provider or pharmacist will be able to calculate the copay costs with your current insurance.
What is Retevmo?
Retevmo is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Loxo Oncology, Inc., a subsidiary of Eli Lilly and Company.
Retevmo is a kinase inhibitor for the treatment of:
- Adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC)
- Adult and pediatric patients 12 years of age and older with advanced or metastatic RET-mutant medullary thyroid cancer (MTC) requiring systemic therapy
- Adult and pediatric patients 12 years of age and older with advanced or metastatic RET fusion-positive thyroid cancer requiring systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate)
This is approved under accelerated approval based on the overall response rate and duration of response.
What doses of Retevmo are available?
Retevmo is available in capsule form, in the following doses: 40 mg, 80 mg.
Patients are selected for treatment based on the presence of a RET gene fusion or specific RET gene mutation (MTC). The recommended dosage in adults and pediatric patients 12 years of age or older is dependent on weight:
- Less than 50 kg – 120 mg orally twice daily
- 50 kg or greater: 160 mg orally twice daily. Reduce dose in patients with severe hepatic impairment
Always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.
Retevmo active ingredients
Retevmo contains the active ingredient selpercatinib, a kinase inhibitor.
Retevmo side effects
The most common side effects of Retevmo in clinical trials include:
- Increased aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatinine (which can measure kidney function), cholesterol, alkaline phosphatase, and blood sugar
- Decreased white blood cells, albumin, platelet count, sodium and calcium
- Dry mouth
- Diarrhea, constipation
- Hypertension (high blood pressure)
- Edema, rash
- Allergic reactions – fever, rash, or pain in muscles or joints
In rare instances, Retevmo can cause more serious side effects. These can include:
- Hemorrhagic Events – permanently discontinue Retevmo
- Impaired Wound Healing
A healthcare professional will assess the benefits of using Retevmo against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Retevmo to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Retevmo drug interactions
Retevmo can interact with other medications. These include:
- H2 receptor antagonists – famotidine, nizatidine, and cimetidine
- Locally acting antacids – aluminum, magnesium, calcium, simethicone, or buffered medicines
- Proton pump inhibitors (PPIs) – dexlansoprazole, esomeprazole, lansoprazole, omeprazole, pantoprazole sodium, rabeprazole
- Strong and Moderate CYP3A Inhibitors
- Strong and Moderate CYP3A Inducers
- CYP2C8 and CYP3A Substrates
This list is not exhaustive and other prescription drugs may interact with Retevmo. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
You should not use Retevmo if you:
- Are allergic to the active ingredient selpercatinib
- Are pregnant or plan to become pregnant – females of reproductive potential should use effective contraception
- Are breastfeeding or plan to breastfeed – do not breastfeed during treatment, and for 1 week after the last dose
Before taking Retevmo, tell your healthcare provider about all your medical conditions, including if you:
- Are taking any of the medications that could interact with Retevmo
- Have liver problems
- Have high blood pressure
- Have heart problems including a condition called QT prolongation
- Have bleeding problems
- Plan to have surgery – stop taking Retevmo at least 7 days before your planned surgery
Retevmo is the trademark brand name for selpercatinib manufactured by Loxo Oncology, Inc. A generic version of selpercatinib is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Retevmo savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.